News

CAR-T cells engineered to attack two leukemia proteins show promise in preclinical tests
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...
CURE2d
Breaking Down What CAR T-Cell Therapy Means for Blood Cancers
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...
In-body CAR-T cell generation proves effective, safe in mice in Stanford Medicine-led study
RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...
American Rifleman1d
Henry Donates Rifles To Support Young Leukemia Victim
Henry Repeating Arms has donated a limited run of 50 “Team Keane” Golden Boy .22 lever-action rifles to support 13-year-old ...
Fighting leukemia by breaking a hidden cell loop
Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...
New leukemia drug offers hope for Iowa family and others
A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi ...
The Scientist2y
Targeting Leukemia with T Cells That Avoid Self-Destruction
After the researchers successfully selected CD7-negative T cells, they engineered the cells to express a CD7-CAR (CD7-CAR CD7-).These engineered cells were resistant to fratricide and displayed potent ...
Fred Hutch3y
Novel transplant approach improves the odds for leukemia patients
Naïve T cells are therefore coated with iron-bearing antibodies, latched to the telltale CD45RA proteins, and voila: They are drawn by a magnet out of the soup of about-to-be transplanted immune cells ...